RKLB · Forward model · Bear case
The Bear case, 20 quarters out
Model as of
Each segment is projected from its own operating driver, rolled up into consolidated cash flow, and discounted back to a fair value per share. The assumptions below are editable — change them and every number on this page moves with them.
Rocket Lab reports two segments, Launch Services and Space Systems, and discloses revenue AND gross profit for both - so the split here is reported, not apportioned, and the only estimated quarters are the three fiscal fourth quarters derived as the full year less the nine months. Neutron and Iridium are separate verticals with no reported past: both carry zero across every historical quarter and start in the projection, which is why nothing has been split out of a disclosed segment to create them. What is assumed rather than reported is everything below gross profit: the 10-Q states management does not review operating expenses by segment, so all research and development and all selling, general and administrative expense sits in the single corporate overhead figure, and every margin glide and capex intensity is the model's own. Overhead is one flat percentage of consolidated revenue; it was 45% in the June quarter on a non-GAAP basis excluding depreciation, and 26% is the flat rate that spends the same dollars over the horizon as an opex base growing at 55% of the rate of revenue - about 22% of revenue by the terminal quarter. The near quarters are therefore flattered and the terminal ones about right. Share count and net cash are pro-forma for the Iridium acquisition at the 20 August price: 598.2M common plus 40.9M preferred, plus 39.2M issued as the stock leg, plus 26.7M if the $1.944bn equity programme is fully drawn; net cash is the June balance sheet less the $2.861bn cash leg, plus those equity proceeds, less Iridium's $1.775bn term loan. That leaves the combined company with roughly no net cash, which is itself a finding.
Shares this page's scenario. Driver and horizon edits stay in your browser — the recipient sees the published model.
Latest: $672M (2031Q2E)
| Period | Value |
|---|---|
| 2023Q2 | $62M |
| 2023Q3 | $68M |
| 2023Q4 | $60M |
| 2024Q1 | $93M |
| 2024Q2 | $106M |
| 2024Q3 | $105M |
| 2024Q4 | $132M |
| 2025Q1 | $123M |
| 2025Q2 | $144M |
| 2025Q3 | $155M |
| 2025Q4 | $180M |
| 2026Q1 | $200M |
| 2026Q2 | $234M |
| 2026Q3E | $248M |
| 2026Q4E | $262M |
| 2027Q1E | $274M |
| 2027Q2E | $287M |
| 2027Q3E | $545M |
| 2027Q4E | $556M |
| 2028Q1E | $567M |
| 2028Q2E | $578M |
| 2028Q3E | $588M |
| 2028Q4E | $598M |
| 2029Q1E | $607M |
| 2029Q2E | $617M |
| 2029Q3E | $626M |
| 2029Q4E | $635M |
| 2030Q1E | $643M |
| 2030Q2E | $652M |
| 2030Q3E | $660M |
| 2030Q4E | $669M |
| 2031Q1E | $671M |
| 2031Q2E | $672M |
Where each case comes from
Beck case — primary sources
The primary sources this case is built from — filings, calls and posts. Where they are claims by an interested party rather than disclosures, every number in the Beck column is what happens if they are taken at face value.
The Iridium acquisition, in Beck's own words
- Jun 29, 2026 This is a defining moment for the space industry and the start of a new era of strategic, accelerated growth for Rocket Lab and Iridium.
- Jun 29, 2026 if you want to do large scale communications globally, you must have spectrum. And for us, this deal really enables us to accelerate our entry into this market.
- Jun 29, 2026 We're not investing in hopes and dreams. We're not pushing all the chips into the center of the table. We're doing another really smart deal. We're buying capability that ensures that it's accretive to the bottom line.
The end-state, and the schedule it rests on
- Aug 10, 2026 Together, these moves position Rocket Lab to accelerate our future into space applications by becoming a self-launching, tier-1 space power that will deliver critical communications capability to millions of users worldwide.
- Aug 10, 2026 Production of the Stage 1 tank is currently aligned with the target delivery of Neutron to the launch pad in Q4 2026.
- Aug 10, 2026 Q2 2026 saw our backlog grow to $2.36 billion - another record - which, combined with new deals in the period since, equates to more than $1 billion in new contracts across launch and space systems already entered into in Q3.
- Aug 13, 2026 Filing the Form S-4 and the FCC applications and receiving U.S. antitrust clearance are all major steps for us in the execution timeline for the Iridium acquisition.
From cash flow to fair value
The published model, discounted at 11.0% a year with an exit multiple of 6.0x on revenue. The sliders above do not change this walk.
| Present value of free cash flow, 20 quarters | −$208M |
| Terminal-year revenue | $2.67B |
| Terminal-year EBITDA | $380M |
| Exit multiple, on revenue | 6.0x |
| Terminal value | $16.04B |
| Discounted at 11.0% a year, terminal value becomes | $9.52B |
| Share of enterprise value from the terminal | 102% |
| Enterprise value | $9.31B |
| Net cash | −$581M |
| Equity value | $8.73B |
| Shares | 0.70B |
| Fair value per share | $12.38 |
| Against the deployed price of $61.96, as of | −80% |
9.0x is what Rocket Lab itself agreed to pay for a mature space-comms business: $8.0bn of enterprise value over Iridium's $884M of trailing revenue. The buyer's own purchase accounting marks $3.32bn of that price as indefinite-lived spectrum, so this is a transaction anchor and not a clean operating multiple; it is kept because the licence is not severable from the revenue it produces.
Read the other way round: at $61.96 the market is paying 28.0x terminal-year revenue, holding every other assumption on this page fixed. That is the number to argue about.
The projected path
| Quarter | Launch Services | Neutron | Space Systems | Iridium services | Revenue | YoY | EBITDA | Capex | FCF | R40 | PV of FCF |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3E | $46M | $0 | $202M | $0 | $248M | +60% | $14M | $36M | −$23M | +51 | −$22M |
| 2026 Q4E | $47M | $0 | $215M | $0 | $262M | +46% | $15M | $36M | −$21M | +37 | −$20M |
| 2027 Q1E | $48M | $0 | $227M | $0 | $274M | +37% | $17M | $37M | −$20M | +30 | −$18M |
| 2027 Q2E | $49M | $0 | $238M | $0 | $287M | +22% | $18M | $37M | −$18M | +16 | −$17M |
| 2027 Q3E | $50M | $40M | $248M | $206M | $545M | +120% | $56M | $94M | −$39M | +113 | −$34M |
| 2027 Q4E | $51M | $42M | $258M | $205M | $556M | +113% | $59M | $93M | −$33M | +107 | −$29M |
| 2028 Q1E | $52M | $43M | $268M | $204M | $567M | +107% | $63M | $92M | −$29M | +102 | −$24M |
| 2028 Q2E | $53M | $45M | $277M | $203M | $578M | +101% | $66M | $91M | −$24M | +97 | −$20M |
| 2028 Q3E | $54M | $47M | $285M | $202M | $588M | +8% | $70M | $90M | −$20M | +4 | −$16M |
| 2028 Q4E | $55M | $49M | $293M | $201M | $598M | +7% | $73M | $89M | −$16M | +5 | −$12M |
| 2029 Q1E | $56M | $50M | $301M | $200M | $607M | +7% | $76M | $88M | −$12M | +5 | −$9M |
| 2029 Q2E | $57M | $52M | $308M | $199M | $617M | +7% | $79M | $87M | −$9M | +5 | −$6M |
| 2029 Q3E | $58M | $54M | $315M | $199M | $626M | +6% | $82M | $87M | −$5M | +6 | −$4M |
| 2029 Q4E | $59M | $57M | $321M | $198M | $635M | +6% | $84M | $86M | −$2M | +6 | −$1M |
| 2030 Q1E | $60M | $59M | $328M | $197M | $643M | +6% | $87M | $86M | $651994 | +6 | $440841 |
| 2030 Q2E | $61M | $61M | $333M | $197M | $652M | +6% | $89M | $86M | $3M | +6 | $2M |
| 2030 Q3E | $62M | $64M | $339M | $196M | $660M | +6% | $92M | $86M | $5M | +6 | $3M |
| 2030 Q4E | $63M | $66M | $345M | $195M | $669M | +5% | $94M | $86M | $7M | +6 | $4M |
| 2031 Q1E | $64M | $63M | $350M | $195M | $671M | +4% | $96M | $85M | $10M | +6 | $6M |
| 2031 Q2E | $65M | $58M | $355M | $194M | $672M | +3% | $98M | $83M | $12M | +5 | $7M |
Every row is projected. A year-over-year change is shown only where the quarter it compares against exists — an em dash means there is no comparable quarter, not a flat year.
Model revisions
Assumptions are marked to reality as each quarter prints. Every change is appended here, with the fair value the model produced at the time, so the model's own history stays visible.
| Date | Fair value then | Note |
|---|---|---|
| 2026-08-21 | $33.09 | First publication. Two disclosed segments plus Neutron and Iridium as delayed lines with no reported past; exit multiple anchored to the 9.0x Rocket Lab itself agreed to pay for Iridium. |
| 2026-08-25 | $33.23 | Merger registration statement read in full. Iridium EBITDA margins moved to management's own disclosed forecast (55.5% to 64.2%); net cash reduced by the $247M of transaction and issuance costs paid at closing; exit-multiple rationale corrected to say the 9.0x anchor is 41% an indefinite-lived spectrum mark. Fair value excludes the spectrum, and now says so. |